Medical Photonics Group, Ecole Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
J Photochem Photobiol B. 2010 Jan 21;98(1):69-76. doi: 10.1016/j.jphotobiol.2009.11.006. Epub 2009 Nov 26.
Photodynamic therapy (PDT) with Visudyne acts by direct cellular phototoxicity and/or by an indirect vascular-mediated effect. Here, we demonstrate that the vessel integrity interruption by PDT can promote the extravasation of a macromolecular agent in normal tissue. To obtain extravasation in normal tissue PDT conditions were one order of magnitude more intensive than the ones in tissue containing neovessels reported in the literature. Fluorescein isothiocyanate dextran (FITC-D, 2000 kDa), a macromolecular agent, was intravenously injected 10 min before (LK0 group, n=14) or 2h (LK2 group, n=16) after Visudyne-mediated PDT in nude mice bearing a dorsal skin fold chamber. Control animals had no PDT (CTRL group, n=8). The extravasation of FITC-D from blood vessels in striated muscle tissue was observed in both groups in real-time for up to 2500 s after injection. We also monitored PDT-induced leukocyte rolling in vivo and assessed, by histology, the corresponding inflammatory reaction score in the dorsal skin fold chambers. In all animals, at the applied PDT conditions, FITC-D extravasation was significantly enhanced in the PDT-treated areas as compared to the surrounding non-treated areas (p<0.0001). There was no FITC-D leakage in the control animals. Animals from the LK0 group had significantly less FITC-D extravasation than those from the LK2 group (p=0.0002). In the LK0 group FITC-D leakage correlated significantly with the inflammation (p<0.001). At the selected conditions, Visudyne-mediated PDT promotes vascular leakage and FITC-D extravasation into the interstitial space of normal tissue. The intensity of vascular leakage depends on the time interval between PDT and FITC-D injection. This concept could be used to locally modulate the delivery of macromolecules in vivo.
光动力疗法(PDT)用 Visudyne 通过直接细胞光毒性和/或间接血管介导的作用起作用。在这里,我们证明 PDT 引起的血管完整性中断可以促进大分子药物在正常组织中的渗漏。为了在正常组织中获得渗漏,PDT 条件的强度比文献中报道的含有新生血管的组织中的强度高一个数量级。荧光素异硫氰酸酯葡聚糖(FITC-D,2000 kDa),一种大分子药物,在 Visudyne 介导的 PDT 后 10 分钟(LK0 组,n=14)或 2 小时(LK2 组,n=16)前静脉内注射。裸鼠背部皮肤褶皱室中携带。对照动物没有 PDT(CTRL 组,n=8)。在注射后长达 2500 秒内,实时观察到这两组动物的 FITC-D 从横纹肌组织中的血管漏出。我们还监测了体内 PDT 诱导的白细胞滚动,并通过组织学评估了背部皮肤褶皱室中的相应炎症反应评分。在所有动物中,在应用的 PDT 条件下,与周围未处理区域相比,PDT 处理区域的 FITC-D 渗漏显着增加(p<0.0001)。对照动物没有 FITC-D 泄漏。LK0 组动物的 FITC-D 渗漏明显少于 LK2 组(p=0.0002)。在 LK0 组中,FITC-D 泄漏与炎症显着相关(p<0.001)。在选定的条件下,Visudyne 介导的 PDT 可促进血管渗漏和 FITC-D 向正常组织间质空间的外渗。血管渗漏的强度取决于 PDT 和 FITC-D 注射之间的时间间隔。该概念可用于在体内局部调节大分子的递送。